Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Sell
49
DD Quote, Financials, Valuation and Earnings
Last price:
$77.49
Seasonality move
:
2.79%
Day range:
$77.09 - $78.34
52-week range:
$61.14 - $90.06
Dividend yield:
1.98%
P/E ratio:
40.35x
P/S ratio:
2.66x
P/B ratio:
1.32x
Volume:
2.3M
Avg. volume:
2.2M
1-year change:
6.01%
Market cap:
$32B
Revenue:
$12.1B
EPS (TTM):
$1.90
Analysts' Opinion
-
Consensus RatingDuPont de Nemours has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $95.38, DuPont de Nemours has an estimated upside of 24.41% from its current price of $77.47.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $44.00 representing 42.6% downside risk from its current price of $77.47.
Fair Value
-
According to the consensus of 13 analysts, DuPont de Nemours has 24.41% upside to fair value with a price target of $95.38 per share.
DD vs. S&P 500
-
Over the past 5 trading days, DuPont de Nemours has overperformed the S&P 500 by 1.06% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
DuPont de Nemours does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DuPont de Nemours has grown year-over-year revenues for 2 quarters straight. In the most recent quarter DuPont de Nemours reported revenues of $3.2B.
Earnings Growth
-
DuPont de Nemours has grown year-over-year earnings for 1 quarter straight. In the most recent quarter DuPont de Nemours reported earnings per share of $1.08.
Enterprise value:
38B
EV / Invested capital:
--
Price / LTM sales:
2.66x
EV / EBIT:
41.44x
EV / Revenue:
3.11x
PEG ratio (5yr expected):
--
EV / Free cash flow:
30.61x
Price / Operating cash flow:
26.19x
Enterprise value / EBITDA:
18.03x
Gross Profit (TTM):
$4.4B
Return On Assets:
2.11%
Net Income Margin (TTM):
6.55%
Return On Equity:
3.28%
Return On Invested Capital:
2.5%
Operating Margin:
16.42%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $13.2B | $12.3B | $12.2B | $3.1B | $3.2B | |
| Gross Profit | $4.7B | $4.3B | $4.4B | $1.1B | $1.2B | |
| Operating Income | $2B | $1.8B | $1.8B | $461M | $524M | |
| EBITDA | $3B | $2.9B | $2.1B | $804M | $979M | |
| Diluted EPS | $3.52 | $9.66 | $1.90 | $0.70 | $1.08 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.6B | $8.5B | $14.4B | $7.9B | $6.4B | |
| Total Assets | $72.1B | $46B | $44.1B | $39.1B | $37.5B | |
| Current Liabilities | $7B | $4.2B | $6B | $3.7B | $2.8B | |
| Total Liabilities | $34B | $18.8B | $18.6B | $14.5B | $12.8B | |
| Total Equity | $38.1B | $27.2B | $25.5B | $24.6B | $24.7B | |
| Total Debt | $24.2B | $10.6B | $11.8B | $8.1B | $7.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.7B | $1.1B | $2.1B | $740M | $737M | |
| Cash From Investing | $197M | $8.1B | $333M | -$1.9B | -$423M | |
| Cash From Financing | -$1B | -$9.6B | -$2.3B | -$2B | -$140M | |
| Free Cash Flow | $1.1B | -$1.3B | $1.2B | -$1.1B | $309M | |
DD
Sector
Market Cap
$32B
$18.7M
Price % of 52-Week High
85.12%
60.22%
Dividend Yield
1.98%
0%
Shareholder Yield
3.37%
1.57%
1-Year Price Total Return
3.99%
-14.61%
Beta (5-Year)
1.354
1.044
Dividend yield:
1.98%
Annualized payout:
$1.44
Payout ratio:
79.1%
Growth streak:
2 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$75.29
200-day SMA
Sell
Level
$80.38
Bollinger Bands (100)
Sell
Level
78.35 - 85.77
Chaikin Money Flow
Buy
Level
622.9M
20-day SMA
Buy
Level
$75.99
Relative Strength Index (RSI14)
Buy
Level
50.77
ADX Line
Buy
Level
33.69
Williams %R
Sell
Level
-17.5681
50-day SMA
Sell
Level
$80.11
MACD (12, 26)
Sell
Level
-1.23
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Neutral
Level
275M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1327)
Buy
CA Score
(Annual)
Level (0.3805)
Buy
Beneish M-Score
(Annual)
Level (-2.6437)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (4.6647)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to spin off its electronics business by the end of 2025.
Stock Forecast FAQ
In the current month, DD has received 9 Buy ratings 4 Hold ratings, and 0 Sell ratings. The DD average analyst price target in the past 3 months is $95.38.
-
Where Will DuPont de Nemours Stock Be In 1 Year?
According to analysts, the consensus estimate is that DuPont de Nemours share price will rise to $95.38 per share over the next 12 months.
-
What Do Analysts Say About DuPont de Nemours?
Analysts are divided on their view about DuPont de Nemours share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DuPont de Nemours is a Sell and believe this share price will drop from its current level to $44.00.
-
What Is DuPont de Nemours's Price Target?
The price target for DuPont de Nemours over the next 1-year time period is forecast to be $95.38 according to 13 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is DD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DuPont de Nemours is a Buy. 9 of 13 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of DD?
You can purchase shares of DuPont de Nemours via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DuPont de Nemours shares.
-
What Is The DuPont de Nemours Share Price Today?
DuPont de Nemours was last trading at $77.49 per share. This represents the most recent stock quote for DuPont de Nemours. Yesterday, DuPont de Nemours closed at $77.47 per share.
-
How To Buy DuPont de Nemours Stock Online?
In order to purchase DuPont de Nemours stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 2.83% over the past day.
Buy
53
QMCO alert for Jan 17
Quantum [QMCO] is down 15.61% over the past day.
Sell
34
NGVT alert for Jan 17
Ingevity [NGVT] is up 1.31% over the past day.
